Pro-angiogenic compounds, such as VEGF, CXCL8, FGF, and MMPs, are produced by BMSCs and osteoclasts, and they are frequently induced by the interaction between AML cells and BMSCs, as well as by genetic or transcriptional alterations. This evidence concerns the gene CXCL8 and acute myeloid leukemia.